eClinical Solutions market is expected to grow from USD 5.93 billion in 2019 to USD 14.07 billion by 2026 at a CAGR of 13.14% from 2020 to 2026.
eClinical solutions manage the clinical technologies and expertise to facilitate the acceleration of the clinical development process. The demand for these solutions is on an increase with the rise in clinical trials within the pharmaceutical and biotechnology industries. Market size is witnessing an enormous development due to factors like a rise within the number of consumers choosing eClinical solutions, increasing research and development during this domain, and growth in government grants to validate the clinical trials. The global market is predicted to witness significant growth during the forecast period due to factors like rising in clinical trials by the pharmaceutical and biotechnology companies, specialize in R&D activities to develop innovative eClinical solutions, and grants from the govt to substantiate the clinical trials. The high cost of implementation including the dearth of skilled professionals can pose a serious obstacle for the expansion of the market. The global market is segregated on the basis of Product as Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), Clinical Trial Management Systems (CTMS), Clinical Analytics Platform, Randomization and Trial Supply Management (RTMS), Clinical Data Integration Platform, Electronic Clinical Outcome Assessment (eCOA), Safety Solutions, Electronic Trail Master Files (eTMF), Regulatory Information Management Solutions (RIMS), and Others. Based on Delivery Mode the global market is segmented in Web-hosted (On-demand), Licensed Enterprise (On-premise), and Cloud-based. Based on Clinical Trial Phase the global market is segmented in Phase I, Phase II, Phase III, and Phase IV. Based on End User, the global market is segmented in Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Consulting Service Companies, Medical Device Manufacturers, Hospitals, and Academic Research Institutions.
The global market report provides geographical analysis covering regions, such as Europe, North America, Asia Pacific, and the Rest of The World. The market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Oracle Corporation, Medidata Solutions, Inc., PAREXEL International Corporation, BioClinica, Inc., DATATRAK International, Inc., ERT, eClinical Solutions, Inc., MaxisIT Inc., Bio-Optronics, Inc., Merge Healthcare Incorporated, and others are among the major players in the market. The companies studied in terms of product strategy and various n several growths and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.
The global eClinical Solutions market has been segmented as below:
By Product
By Delivery Mode
By Clinical Trial Phase
By End-User
By Region
By Company
The report covers the below scope:
The years considered for the study are as follows:
Report Scope:
The global market report scope includes a detailed study covering underlying factors influencing the industry trends. The report covers the analysis of regional and country-level market dynamics. The scope also covers a competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes a detailed competitive outlook covering market shares and profiles key participants in the market share. Major industry players with significant revenue share include Oracle Corporation, Medidata Solutions, Inc., PAREXEL International Corporation, BioClinica, Inc., DATATRAK International, Inc., ERT, eClinical Solutions, Inc., MaxisIT Inc., Bio-Optronics, Inc., Merge Healthcare Incorporated, and others.
Why Buy this Report:
Target Audience:
The report targeted the existing players in the industry is as follows:
Free and Paid Customization based on the requirement
Report Content
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
5.1 Introduction
5.2 Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Clinical Trial Management Systems (CTMS)
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Clinical Analytics Platform
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Randomization and Trial Supply Management (RTMS)
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Clinical Data Integration Platform
5.6.1 Market Overview
5.6.2 Market Size and Forecast
5.7 Electronic Clinical Outcome Assessment (eCOA)
5.7.1 Market Overview
5.7.2 Market Size and Forecast
5.8 Safety Solutions
5.8.1 Market Overview
5.8.2 Market Size and Forecast
5.9 Electronic Trail Master Files (eTMF)
5.9.1 Market Overview
5.9.2 Market Size and Forecast
5.10 Regulatory Information Management Solutions (RIMS)
5.10.1 Market Overview
5.10.2 Market Size and Forecast
5.11 Others
5.11.1 Market Overview
5.11.2 Market Size and Forecast
6.1 Introduction
6.2 Web-hosted (On-demand)
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Licensed Enterprise (On-premise)
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Cloud-based
6.4.1 Market Overview
6.4.2 Market Size and Forecast
7.1 Introduction
7.2 Phase I
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Phase II
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Phase III
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Phase IV
7.5.1 Market Overview
7.5.2 Market Size and Forecast
8.1 Introduction
8.2 Pharmaceutical and Biopharmaceutical Companies
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 Contract Research Organizations
8.3.1 Market Overview
8.3.2 Market Size and Forecast
8.4 Consulting Service Companies
8.4.1 Market Overview
8.4.2 Market Size and Forecast
8.5 Medical Device Manufacturers
8.5.1 Market Overview
8.5.2 Market Size and Forecast
8.6 Hospitals
8.6.1 Market Overview
8.6.2 Market Size and Forecast
8.7 Academic Research Institutions
8.7.1 Market Overview
8.7.2 Market Size and Forecast
9.1 Introduction
9.2 Europe
9.2.1 Europe Market, By Product
9.2.2 Europe Market, By Delivery Mode
9.2.3 Europe Market, By Clinical Trial Phase
9.2.4 Europe Market, By End User
9.3 North America
9.3.1 North America Market, By Product
9.3.2 North America Market, By Delivery Mode
9.3.3 North America Market, By Clinical Trial Phase
9.3.4 North America Market, By End User
9.4 Asia Pacific
9.4.1 Asia Pacific Market, By Product
9.4.2 Asia Pacific Market, By Delivery Mode
9.4.3 Asia Pacific Market, By Clinical Trial Phase
9.4.4 Asia Pacific Market, By End User
9.5 Rest of The World
9.5.1 Rest of The World Market, By Product
9.5.2 Rest of The World Market, By Delivery Mode
9.5.3 Rest of The World Market, By Clinical Trial Phase
9.5.4 Rest of The World Market, By End User
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
(Overview, Key Financials, Recent Developments, Product and Service Offering)
The global eClinical Solutions market has been segmented as below:
By Product
By Delivery Mode
By Clinical Trial Phase
By End-User
By Region
By Company